GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedReleaf Corp (OTCPK:MEDFF) » Definitions » Total Tax Payable

MedReleaf (MedReleaf) Total Tax Payable : $0.00 Mil (As of Mar. 2018)


View and export this data going back to 2017. Start your Free Trial

What is MedReleaf Total Tax Payable?

MedReleaf's Total Tax Payable for the quarter that ended in Mar. 2018 was $0.00 Mil.

MedReleaf's annual Total Tax Payable increased from Mar. 2016 ($0.00 Mil) to Mar. 2017 ($1.34 Mil) but then declined from Mar. 2017 ($1.34 Mil) to Mar. 2018 ($0.00 Mil).


MedReleaf Total Tax Payable Historical Data

The historical data trend for MedReleaf's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedReleaf Total Tax Payable Chart

MedReleaf Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18
Total Tax Payable
- - - 1.34 -

MedReleaf Quarterly Data
Mar14 Mar15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.34 - - - -

MedReleaf Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.


MedReleaf Total Tax Payable Related Terms

Thank you for viewing the detailed overview of MedReleaf's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


MedReleaf (MedReleaf) Business Description

Traded in Other Exchanges
N/A
Address
MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence.